Rosmantuzumab (OMP-131R10) is a humanized monoclonal antibody against R-spondin 3 (RSPO3). Rosmantuzumab has potential antitumor activity and can be used to study advanced relapsed refractory solid tumors.
CAS Number:
[1684393-04-1]
Target:
OMP-131R10
* VAT and and shipping costs not included. Errors and price changes excepted